Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12536074rdf:typepubmed:Citationlld:pubmed
pubmed-article:12536074lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12536074lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:12536074lifeskim:mentionsumls-concept:C0015127lld:lifeskim
pubmed-article:12536074lifeskim:mentionsumls-concept:C1326205lld:lifeskim
pubmed-article:12536074lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:12536074lifeskim:mentionsumls-concept:C0332325lld:lifeskim
pubmed-article:12536074lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:12536074lifeskim:mentionsumls-concept:C0251991lld:lifeskim
pubmed-article:12536074pubmed:issue1lld:pubmed
pubmed-article:12536074pubmed:dateCreated2003-1-21lld:pubmed
pubmed-article:12536074pubmed:abstractTextProtein kinase B (PKB), a kinase downstream of phosphatidylinositol 3-kinase (PI3-kinase) provides anti-apoptotic and survival signals via phosphorylation of various targets. Inhibiting PI3-kinase with a 12 h exposure to 10 microM LY294002 induces levels of apoptosis of 30.39+/-1.53% in the KB-V1 multidrug resistant (MDR) cell line compared to 4.54+/-1.00% in drug sensitive KB-3-1 cells (P<0.001). This occurred in conjunction with a preferential reduction in activated PKB in MDR cells. These results suggest the PI3-kinase/PKB signalling pathway is important for the survival of MDR cells and inhibition of this pathway results in the selective induction of apoptosis in MDR cells.lld:pubmed
pubmed-article:12536074pubmed:languageenglld:pubmed
pubmed-article:12536074pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:citationSubsetIMlld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12536074pubmed:statusMEDLINElld:pubmed
pubmed-article:12536074pubmed:monthFeblld:pubmed
pubmed-article:12536074pubmed:issn0304-3835lld:pubmed
pubmed-article:12536074pubmed:authorpubmed-author:KellettG LGLlld:pubmed
pubmed-article:12536074pubmed:authorpubmed-author:WarrJ RJRlld:pubmed
pubmed-article:12536074pubmed:authorpubmed-author:QuinnD MDMlld:pubmed
pubmed-article:12536074pubmed:authorpubmed-author:NicholsonK...lld:pubmed
pubmed-article:12536074pubmed:issnTypePrintlld:pubmed
pubmed-article:12536074pubmed:day10lld:pubmed
pubmed-article:12536074pubmed:volume190lld:pubmed
pubmed-article:12536074pubmed:ownerNLMlld:pubmed
pubmed-article:12536074pubmed:authorsCompleteYlld:pubmed
pubmed-article:12536074pubmed:pagination31-6lld:pubmed
pubmed-article:12536074pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:meshHeadingpubmed-meshheading:12536074...lld:pubmed
pubmed-article:12536074pubmed:year2003lld:pubmed
pubmed-article:12536074pubmed:articleTitleLY294002, an inhibitor of phosphatidylinositol-3-kinase, causes preferential induction of apoptosis in human multidrug resistant cells.lld:pubmed
pubmed-article:12536074pubmed:affiliationDepartment of Biology, University of York, PO Box 373, York YO10 5YW, UK.lld:pubmed
pubmed-article:12536074pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12536074pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12536074lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12536074lld:pubmed